SCHEMBL9837374

SCHEMBL9837374

Oc1cccc(-c2cn3c(n2)sc2ccccc23)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 3/20 0.53
SMN1; SMN2 Q16637 3/20 0.53
LMNA P02545 2/20 0.53
TP53 P04637 2/20 0.53
MAPT P10636 2/20 0.53
TSHR P16473 1/20 0.53
ATM Q13315 1/20 0.53
TDP1 Q9NUW8 1/20 0.53
POLB P06746 1/20 0.50
NFKB1 P19838 1/20 0.50
NFKB2 Q00653 1/20 0.50
RELA Q04206 1/20 0.50
HSD17B10 Q99714 1/20 0.50
FLT3 P36888 1/20 0.47
THRB P10828 3/20 0.46
RXFP1 Q9HBX9 1/20 0.44
NPC1 O15118 1/20 0.44
ALDH1A1 P00352 1/20 0.44
MET P08581 1/20 0.44
HSD17B1 P14061 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11011725 0.90 MAPT (0.51) RAB9ASMN1; SMN2LMNATP53MAPT
SCHEMBL11005773 0.86 MAPT (0.48) RAB9ASMN1; SMN2LMNATP53MAPT
SCHEMBL10806421 0.86 MAPT (0.52) RAB9ASMN1; SMN2LMNATP53MAPT
SCHEMBL84416 0.85 RAB9A (0.64) RAB9ASMN1; SMN2LMNATP53MAPT
SCHEMBL13394275 0.84 MAPT (0.52) RAB9ASMN1; SMN2LMNATP53MAPT
SCHEMBL11005766 0.84 MAPT (0.55) RAB9ASMN1; SMN2LMNATP53MAPT
SCHEMBL11012504 0.84 MAPT (0.51) RAB9ASMN1; SMN2LMNATP53MAPT
SCHEMBL7763808 0.83 MAPT (0.53) RAB9ASMN1; SMN2LMNATP53MAPT
SCHEMBL11010264 0.83 MAPT (0.53) RAB9ASMN1; SMN2LMNATP53MAPT
SCHEMBL11011244 0.83 TP53 (0.67) RAB9ASMN1; SMN2LMNATP53MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4497817-A ANTIALLERGENS-IMMUNOSUPPRESSIVE AGENTS YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) 1985-02-05 US claimed
EP-0454773-A1 NOVEL PRODRUG DERIVATIVES OF BIOLOGICALLY ACTIVE AGENTS CONTAINING HYDROXYL GROUPS OR NH-ACIDIC GROUPS Bundgaard, Hans (DK) 1991-11-06 EP disclosed
WO-1990008128-A1 NOVEL PRODRUG DERIVATIVES OF BIOLOGICALLY ACTIVE AGENTS CONTAINING HYDROXYL GROUPS OR NH-ACIDIC GROUPS BUNDGAARD HANS (DK) 1990-07-26 WO disclosed
EP-0082712-B1 2-PHENYLIMIDAZO(2,1-B)BENZOTHIAZOLE COMPOUNDS, SALTS THEREOF, PROCESS FOR PRODUCING THEM, AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) 1987-06-16 EP disclosed
US-4497817-A ANTIALLERGENS-IMMUNOSUPPRESSIVE AGENTS YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) 1985-02-05 US disclosed
US-4464384-A SUPPRESSANTS OF IMMUNE RESPONSE YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) 1984-08-07 US disclosed
EP-0082712-A2 2-Phenylimidazo(2,1-b)benzothiazole compounds, salts thereof, process for producing them, and pharmaceutical compositions containing them YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP) 1983-06-29 EP disclosed